Mr. Mark Upsdell reports

RAPID DOSE THERAPEUTICS ENTERS SUPPLIER AND PURCHASE AGREEMENT WITH A LEADING GAS AND CONVENIENCE STORE RETAILER FOR NUTRACEUTICAL AND VITAMIN PRODUCTS

Rapid Dose Therapeutics Corp. has entered into a supplier and purchase agreement with a leading gas and convenience store retailer.

Rapid Dose Therapeutics's Quickstrip Sleep (melatonin) and Quickstrip Energy (caffeine) products will be available at 300 retail stores across Ontario beginning this October, followed by an additional 400 locations throughout Ontario. These unique products will be featured in a new innovation section within each store.

"Gaining exposure of our Quickstrip branded products in this prominent convenience retail chain is an excellent win for our team as it will help to quickly drive market awareness of our innovative offerings," said Mark Upsdell, chief executive officer, Rapid Dose Therapeutics. "This agreement broadens the consumer penetration of Quickstrip products, leveraging this leading retailer's expansive network of stores."

Mr. Upsdell continues, "Additionally, further updates will be made over the coming weeks as new distribution deals are announced."

The supplier and purchase agreement was signed on Aug. 24, 2022, with the initial purchase order dated Sept. 15, 2022.

About Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product, Quickstrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient.

We seek Safe Harbor.